Answers are grounded in this paper and cite their sources.
The increasing complexity and competitiveness of the pharmaceutical industry are driving the need for innovative technological solutions. This article explores the use of Artificial Intelligence (AI) in the German pharmaceutical sector, with a focus on addressing key challenges related to regulation, market dynamics, internal structures, and technological capabilities. Through a combination of systematic literature review and qualitative expert interviews, the study identifies major problem areas and derives corresponding AI-based innovation potentials in departments such as research, human resources, and quality management. The findings demonstrate that a strategically guided implementation of AI can lead to substantial process improvements and foster long-term competitive advantages. To facilitate this transformation, the study concludes with actionable recommendations aimed at advancing the integration of AI beyond isolated pilot projects and towards broad, sustainable application within the industry. By combining a systematic literature review with in-depth expert interviews, this study not only provides an overview of the current state of knowledge but, thanks to its qualitative methodology, also offers new insights into the decision-making processes and perceptions of industry experts.
No takes yet. Share an insight, caveat, or question.
Aman et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: